Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 16MG Updated Report 2024-04-17 218700
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 16MG 12.5MG Updated Report 2024-04-17 211765
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 25MG 32MG Updated Report 2024-04-17 211777
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 25MG 32MG Updated Report 2024-04-17 211774
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 32MG Updated Report 2024-04-17 211771
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Actual shortage 12.5MG 32MG Updated Report 2024-04-17 211768
JAMP HYDROXYCHLOROQUINE SULFATE JAMP PHARMA CORPORATION Resolved 200MG Updated Report 2024-04-17 221982
JAMP ENALAPRIL JAMP PHARMA CORPORATION Resolved 5MG Updated Report 2024-04-17 218861
JAMP-CANDESARTAN JAMP PHARMA CORPORATION Resolved 8MG Updated Report 2024-04-17 218717
JAMP-SOLIFENACIN JAMP PHARMA CORPORATION Resolved 10MG Updated Report 2024-04-17 162505

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-VERAPAMIL MYLAN PHARMACEUTICALS ULC Discontinued 80MG Updated Report 2024-04-12 224846
TD ADSORBED SANOFI PASTEUR LIMITED To be discontinued 5LF 2LF Updated Report 2024-04-10 206909
PEDIACEL SANOFI PASTEUR LIMITED To be discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-04-10 206912
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% New Report 2024-04-09 224698
DENTICARE CHLORHEXIDINE GLUCONATE ORAL RINSE 0.12% AMD MEDICOM INC Discontinued 0.12% Updated Report 2024-04-09 224713
PAXIL TAB 30MG GLAXOSMITHKLINE INC To be discontinued 30MG New Report 2024-04-05 224430
PAXIL TAB 10MG GLAXOSMITHKLINE INC To be discontinued 10MG New Report 2024-04-05 224405
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-04-04 224347
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-04-04 224344
EVUSHELD ASTRAZENECA CANADA INC Discontinued 150MG 150MG Updated Report 2024-04-04 224094
SANDOZ OMEPRAZOLE SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-04-04 224216
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-04-03 224180
SANDOZ D-FORTE SANDOZ CANADA INCORPORATED Discontinued 50000UNIT Updated Report 2024-04-03 224169
TEVA-IRBESARTAN TEVA CANADA LIMITED Discontinued 75MG New Report 2024-04-01 224049
APO-CARVEDILOL APOTEX INC To be discontinued 12.5MG Updated Report 2024-04-01 217493
THALOMID BRISTOL-MYERS SQUIBB CANADA Discontinued 200MG Updated Report 2024-04-01 205531
FLAGYL SANOFI-AVENTIS CANADA INC To be discontinued 10% New Report 2024-03-28 223877
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-03-27 204160
REPATHA AMGEN CANADA INC To be discontinued 120MG New Report 2024-03-26 223420
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP STERIMAX INC To be discontinued 10MG New Report 2024-03-22 223145